Swiss National Bank’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.96M | Buy |
159,400
+1,100
| +0.7% | +$28.5K | ﹤0.01% | 1482 |
|
|
2025
Q4 | $4.02M | Buy |
158,300
+25,700
| +19% | +$573K | ﹤0.01% | 1476 |
|
|
2025
Q3 | $2.14M | Buy |
132,600
+2,800
| +2% | +$45.3K | ﹤0.01% | 1824 |
|
|
2025
Q2 | $2.08M | Sell |
129,800
-1,800
| -1% | -$27.2K | ﹤0.01% | 1796 |
|
|
2025
Q1 | $2.25M | Buy |
131,600
+30,800
| +31% | +$644K | ﹤0.01% | 1692 |
|
|
2024
Q4 | $2.5M | Buy |
100,800
+1,200
| +1% | +$34K | ﹤0.01% | 1729 |
|
|
2024
Q3 | $2.84M | Hold |
99,600
| – | – | ﹤0.01% | 1656 |
|
|
2024
Q2 | $2.63M | Hold |
99,600
| – | – | ﹤0.01% | 1673 |
|
|
2024
Q1 | $3.22M | Hold |
99,600
| – | – | ﹤0.01% | 1568 |
|
|
2023
Q4 | $4.2M | Sell |
99,600
-29,500
| -23% | -$1.09M | ﹤0.01% | 1392 |
|
|
2023
Q3 | $4.96M | Buy |
129,100
+15,700
| +14% | +$355K | ﹤0.01% | 1285 |
|
|
2023
Q2 | $2.15M | Buy |
113,400
+29,800
| +36% | +$556K | ﹤0.01% | 1839 |
|
|
2023
Q1 | $1.3M | Sell |
83,600
-9,900
| -11% | -$172K | ﹤0.01% | 2092 |
|
|
2022
Q4 | $1.66M | Sell |
93,500
-1,600
| -2% | -$20.1K | ﹤0.01% | 2019 |
|
|
2022
Q3 | $531K | Hold |
95,100
| – | – | ﹤0.01% | 2544 |
|
|
2022
Q2 | $371K | Hold |
95,100
| – | – | ﹤0.01% | 2677 |
|
|
2022
Q1 | $524K | Buy |
95,100
+6,400
| +7% | +$39.9K | ﹤0.01% | 2597 |
|
|
2021
Q4 | $756K | Buy |
88,700
+13,100
| +17% | +$108K | ﹤0.01% | 2566 |
|
|
2021
Q3 | $657K | Hold |
75,600
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q2 | $799K | Sell |
75,600
-1,900
| -2% | -$26.5K | ﹤0.01% | 2546 |
|
|
2021
Q1 | $1.24M | Hold |
77,500
| – | – | ﹤0.01% | 2267 |
|
|
2020
Q4 | $3.58M | Buy |
77,500
+3,300
| +4% | +$153K | ﹤0.01% | 1567 |
|
|
2020
Q3 | $2.61M | Buy |
74,200
+22,600
| +44% | +$680K | ﹤0.01% | 1579 |
|
|
2020
Q2 | $1.26M | Buy |
+51,600
| New | +$1.11M | ﹤0.01% | 1966 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
